In a case of consolidation in the Chinese pharma sector, LaNova Medicines is being bought out by minority shareholder Sino Biopharm in a deal valued at around $951 million. Under the terms of the deal ...
Pilot programs are exploring the opportunity to offer farmers improved financing terms based on their adoption of regenerative agriculture. The goal is to bring an expanded scale via financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback